Aurinia Pharmaceuticals
AUPH
AUPH
165 hedge funds and large institutions have $958M invested in Aurinia Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 43 increasing their positions, 50 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
1% less funds holding
Funds holding: 166 → 165 (-1)
4.47% less ownership
Funds ownership: 38.33% → 33.86% (-4.5%)
14% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 50
Holders
165
Holding in Top 10
4
Calls
$118M
Puts
$111M
Top Buyers
| 1 | +$48.9M | |
| 2 | +$22.3M | |
| 3 | +$12.9M | |
| 4 |
KPWS
Kestra Private Wealth Services
Austin,
Texas
|
+$12.7M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$9.95M |
Top Sellers
| 1 | -$78.7M | |
| 2 | -$20.5M | |
| 3 | -$9.51M | |
| 4 |
AS
Altshuler Shaham
Tel Aviv,
Israel
|
-$7.25M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$6.51M |